Skip to content

Validation and prognostic value of the five-repetition sit-to-stand test in patients with severe exacerbation of COPD.

Oct 2026 · Brazilian Journal of Physical Therapy · Vol 31 1, pp. 101675 · 0 citations · 12 references
Medicine

Abstract

Background

A severe exacerbation of COPD (ECOPD) may negatively impact patients' functioning; however, there is a lack of validated, simple, and low-cost tools to assess physical function in this setting. Thus, the aims of this study were to explore the construct validity of the five-repetition sit-to-stand (5STS) test for assessing muscle strength and exercise tolerance, and to investigate its prognostic value in predicting exacerbation-related readmission risk in patients with severe ECOPD.

Methods

This was a prospective observational study. Fifty-eight patients hospitalized with a severe ECOPD were included. At hospital discharge, the 5STS, quadriceps force, six-minute walk test (6MWT), COPD Assessment Test (CAT), and modified Medical Research Council scale were assessed. Exacerbation-related readmissions within six months were collected. Statistical analyses included correlation analysis, receiver operating characteristic (ROC) curve, and Kaplan-Meier survival analysis.

Results

58 patients (mean age of 69 ± 8 years, 45% male, FEV1 41 ± 16% predicted) were included. Within six months, 31% were readmitted. The 5STS showed a significant negative correlation with quadriceps force (r = -0.487) and 6MWT (r = -0.415). The ROC curve analysis demonstrated an AUC of 0.720 (95% CI: 0.588-0.853), with a cut-off of ≥13 seconds identifying patients at higher risk of exacerbation-related readmission. Patients with 5STS <13s had a higher probability of remaining hospitalization-free (86.7%) compared to those with 5STS ≥13s (50%).

Conclusion

The 5STS is correlated with muscle strength and exercise tolerance and has acceptable prognostic value for predicting exacerbation-related admission within six months in patients with severe ECOPD.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.